<unk>  is a monoclonal antibody that inhibits angiogenesis by inhibiting vascular endothelial growth factor A, a mechanism similar to that of Bevacizumab.
Ranibizumab
Ruxolitinib
Abrocitinib
Gilteritinib
Erdafitinib
Sorafenib
Avelumab
Nintedanib